AACR Launches Two Career Development Awards to Encourage Diversity in the Cancer Research Workforce
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) announced the creation of two career development awards (CDAs)...
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) announced the creation of two career development awards (CDAs)...
Fifty years after the signing of the National Cancer Act, rapid progress against cancer for patients continues Medical research...
PHILADELPHIA — The American Association for Cancer Research (AACR) today expressed its gratitude to Francis S. Collins, MD, PhD,...
PHILADELPHIA – A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint...
PHILADELPHIA – In preclinical models, combining an investigational Aurora Kinase A (AURKA) inhibitor with a KRAS inhibitor or a...
PHILADELPHIA – Combination of the KRAS inhibitor sotorasib (Lumakras) with afatinib, a pan-ErbB tyrosine kinaseinhibitor, was feasible in treating...
PHILADELPHIA – In a phase II clinical trial, the drug 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) improved survival for some adolescent and young...
PHILADELPHIA – Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival...
Data could help identify factors that contribute to higher risk PHILADELPHIA – Chinese Americans and Laotian Americans were over...
PHILADELPHIA – A pilot program that provided transgender men and nonbinary people with cervical cancer screening tailored to their...